Joel D Leverson

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 2

Top Topics

Diffuse Large B Cell Lymphoma

Endoplasmic Reticulum Stress

Chronic Lymphocytic Leukemia

Binding Protein

Top Venues

Cancer research communications

Science translational medicine

AbbVie Inc

Northwestern University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

AbbVie Inc Jan 01 2013

United States

Scientific Director :: Oncology Development

Abbott Laboratories Jan 03 2003 - Dec 31 2012

United States

Group Leader :: Oncology Discovery

Education History

Northwestern University Aug 30 1993 - Sep 30 1998

United States

PHD :: Biochemistry, Molecular Biology and Cell Biology

Publications

Dennis Juarez, Roberta Buono, Shannon M Matulis, Vilas A Gupta, Madeleine R Duong, Jacob Yudiono, Madhuri Paul, Sharmila Mallya, Grace Diep, Peter Hsin, Alexander Lu, Sang Mi Suh, Vy M Dong, Andrew W Roberts, Joel D Leverson, Muhammad Jalaluddin, Zhuangzhuang Liu, Orlando F Bueno, Lawrence H Boise, David A Fruman
Statin-induced mitochondrial priming sensitizes multiple myeloma cells to BCL2 and MCL1 inhibitors. Cancer research communications (2023)
J Scott Lee, Andrew W Roberts, Dennis Juarez, Thanh-Trang T Vo, Shruti Bhatt, Lee-Or Herzog, Sharmila Mallya, Richard J Bellin, Suresh K Agarwal, Ahmed Hamed Salem, Tu Xu, Jia Jia, Lingxiao Li, John R Hanna, Matthew S Davids, Angela G Fleischman, Susan O'Brien, Lloyd T Lam, Joel D Leverson, Anthony Letai, Jonathan H Schatz, David A Fruman
Statins enhance efficacy of venetoclax in blood cancers. Science translational medicine 10 (445) (2019)